Osteoarthritis and Chondrocytes: On the Road from Mechanisms to Treatment

Osteoarthritis (OA) is a degenerative whole-joint disease affecting more than 500 million people worldwide, characterized by irreversible tissue loss, chronic pain, and physical disability. The pathogenesis of OA is complex, with risk factors such as age, obesity, and injury contributing to a disruption of cartilage homeostasis. Here we focus on the chondrocyte, the sole mature cell type in cartilage, as an active participant in mediating joint demise rather than a mere casualty. In a healthy joint, chondrocytes are quiescent, but in the OA environment, they transition to a dysfunctional, catabolic state, undergoing pathological changes such as hypertrophy and senescence that drive tissue degradation. The canonical Wnt signaling pathway is a critical regulator of cartilage maintenance, and its dysregulation is a key driver of OA progression, making it a prime therapeutic target. However, translating this knowledge into effective disease-modifying OA drugs (DMOADs) has been challenging. While experimental DMOADs have shown promise, many have faced setbacks in clinical trials. These trials underscore the complexity of OA and highlight the critical need for improved trial design that stratifies patients based on disease stage and structural characteristics. Comparing the pathobiology of different joints, such as the knee and temporomandibular joint (TMJ), further reveals how joint-specific differences in biomechanics and cellular composition can dictate therapeutic responses. Among emerging strategies, Wnt-targeted therapies that stabilize the joint microenvironment by suppressing inflammation and promoting chondrocyte survival hold significant promise. This review consolidates the evidence positioning the chondrocyte as an active driver of OA pathogenesis, rather than a passive casualty, to inform future therapeutic development.

• Publication year

  2025

• Venue

  Journal of dentistry research

• Publication date

  2025-11-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/00220345251385964PMID 41299885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of Safety and Efficacy of a Single Lorecivivint Injection in Patients with Knee Osteoarthritis: A Multicenter, Observational Extension Trial

  2025cited by this paper
• Syndecan-4 inhibition attenuates cartilage degeneration in temporomandibular joint osteoarthritis.

  2024cited by this paper
• 10-hydroxy-2-decenoic acid prevents osteoarthritis by targeting aspartyl β hydroxylase and inhibiting chondrocyte senescence in male mice preclinically

  2024cited by this paper
• Immature bovine cartilage wear is due to fatigue failure from repetitive compressive forces and not reciprocating frictional forces.

  2023influential reference
• Lgr5-expressing secretory cells form a Wnt inhibitory niche in cartilage critical for chondrocyte identity.

  2023cited by this paper
• Role of Wnt signaling pathway in joint development and cartilage degeneration

  2023cited by this paper
• Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021

  2023influential reference
• IκB-ζ signaling promotes chondrocyte inflammatory phenotype, senescence, and erosive joint pathology

  2022cited by this paper
• The Extracellular Matrix of Articular Cartilage Controls the Bioavailability of Pericellular Matrix-Bound Growth Factors to Drive Tissue Homeostasis and Repair

  2022cited by this paper
• Recent Advances in “Functional Engineering of Articular Cartilage Zones by Polymeric Biomaterials Mediated with Physical, Mechanical, and Biological/Chemical Cues”

  2022cited by this paper
• Biomaterials for Recruiting and Activating Endogenous Stem Cells in situ Tissue Regeneration.

  2022cited by this paper
• Osteoarthritis of the Knee.

  2021cited by this paper
• Evidence of vasculature and chondrocyte to osteoblast transdifferentiation in craniofacial synovial joints: Implications for osteoarthritis diagnosis and therapy

  2020cited by this paper
• The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis.

  2020cited by this paper
• Mechanisms and therapeutic implications of cellular senescence in osteoarthritis

  2020cited by this paper
• Wnt/β-catenin signaling may induce senescence of chondrocytes in osteoarthritis

  2020cited by this paper
• LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis

  2020cited by this paper
• Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

  2020cited by this paper
• The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial

  2019cited by this paper
• Effect of Sustained Joint Loading on TMJ Disc Nutrient Environment

  2019cited by this paper
• A Second Career for Chondrocytes—Transformation into Osteoblasts

  2019cited by this paper
• Phenotypic instability of chondrocytes in osteoarthritis: on a path to hypertrophy

  2018influential reference
• The role of metabolism in the pathogenesis of osteoarthritis

  2017cited by this paper
• Wnt/ b -Catenin Signaling, Disease, and Emerging Therapeutic Modalities

  2017cited by this paper
• Epiphyseal bone formation occurs via thyroid hormone regulation of chondrocyte to osteoblast transdifferentiation

  2017cited by this paper
• DOT1L safeguards cartilage homeostasis and protects against osteoarthritis

  2017cited by this paper
• Exploiting endogenous fibrocartilage stem cells to regenerate cartilage and repair joint injury

  2016cited by this paper
• Suppression of NF-κB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury

  2016cited by this paper
• WNT16 antagonises excessive canonical WNT activation and protects cartilage in osteoarthritis

  2016influential reference
• Radiocarbon dating reveals minimal collagen turnover in both healthy and osteoarthritic human cartilage

  2016cited by this paper
• Dual pathways to endochondral osteoblasts: a novel chondrocyte-derived osteoprogenitor cell identified in hypertrophic cartilage

  2015cited by this paper
• Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways

  2015cited by this paper
• Agrin mediates chondrocyte homeostasis and requires both LRP4 and α-dystroglycan to enhance cartilage formation in vitro and in vivo

  2015cited by this paper
• Loss of Frzb and Sfrp1 differentially affects joint homeostasis in instability-induced osteoarthritis.

  2015cited by this paper
• Chondrocytes Directly Transform into Bone Cells in Mandibular Condyle Growth

  2015cited by this paper
• Canonical Wnt signaling skews TGF-β signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8.

  2014cited by this paper
• GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition.

  2014cited by this paper
• Low-density lipoprotein receptor–related protein 5 governs Wnt-mediated osteoarthritic cartilage destruction

  2014cited by this paper
• Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation

  2014cited by this paper
• GREM1, FRZB and DKK1 mRNA levels correlate with osteoarthritis and are regulated by osteoarthritis-associated factors

  2013cited by this paper
• ADAM17 Controls Endochondral Ossification by Regulating Terminal Differentiation of Chondrocytes

  2013cited by this paper
• Stimulation of superficial zone protein accumulation by hedgehog and Wnt signaling in surface zone bovine articular chondrocytes.

  2013cited by this paper
• Wnt/β-catenin signaling and disease.

  2012cited by this paper
• The complex world of WNT receptor signalling

  2012influential reference
• Bone morphogenetic protein-2-induced Wnt/β-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes

  2012cited by this paper
• Unlike Bone, Cartilage Regeneration Remains Elusive

  2012cited by this paper
• The role of mitochondria in osteoarthritis

  2011cited by this paper
• Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin.

  2011cited by this paper
• Roles of β-catenin signaling in phenotypic expression and proliferation of articular cartilage superficial zone cells

  2011cited by this paper
• Osteoarthritis: an update with relevance for clinical practice

  2011cited by this paper
• Indian Hedgehog Roles in Post-natal TMJ Development and Organization

  2010cited by this paper
• Activation of β‐Catenin Signaling in Articular Chondrocytes Leads to Osteoarthritis‐Like Phenotype in Adult β‐Catenin Conditional Activation Mice

  2009cited by this paper
• Temporomandibular disorders.

  2008cited by this paper
• Wnt signal transduction pathways

  2008cited by this paper
• An in situ hybridization study of Runx2, Osterix, and Sox9 in the anlagen of mouse mandibular condylar cartilage in the early stages of embryogenesis

  2008cited by this paper
• Osteoarthritis

  2006influential reference
• Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.

  2005cited by this paper
• Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.

  2005cited by this paper
• Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee.

  2004cited by this paper
• Bone formation via cartilage models: the "borderline" chondrocyte.

  1998cited by this paper
• Temporomandibular disorders.

  1992cited by this paper
• Osteoarthritis of the knee.

  1962cited by this paper

• No citing papers are available for this paper.